Carbazole-containing arylcarboxamides as BACE1 inhibitors

被引：25

作者：

Bertini, Simone ^{[1
]}

Asso, Valentina ^{[1
]}

Ghilardi, Elisa ^{[1
]}

Granchi, Carlotta ^{[1
]}

Manera, Clementina ^{[1
]}

Minutolo, Filippo ^{[1
]}

Saccomanni, Giuseppe ^{[1
]}

Bortolato, Andrea ^{[2
]}

Mason, Jonathan ^{[2
,4
]}

Moro, Stefano ^{[3
]}

Macchia, Marco ^{[1
]}

机构：

[1] Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy

[2] Heptares Therapeut Ltd, Welwyn Garden City AL7 RAX, Herts, England

[3] Univ Padua, Dipartimento Sci Farmaceut, Mol Modeling Sect, I-35131 Padua, Italy

[4] Lundbeck AS, DK-2500 Copenhagen, Denmark

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 22期

关键词：

Alzheimer; BACE1; Carbazole; Molecular docking; Flap; AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURE; DESIGN; MODEL; SITE; MATURATION; PREDICTION; DOCKING;

D O I：

10.1016/j.bmcl.2011.09.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

beta-Secretase (BACE1) is widely recognized as a prime drug target for the treatment of Alzheimer's disease (AD). In this Letter, we report the synthesis and the BACE1 inhibitory activity of novel, variously substituted N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-arylcarboxamides. The best results have been obtained with the introduction of a 4-OMe substituent (IC50 = 3.8 mu M) or a 3,4-dichloro substituent (IC50 = 2.5 mu M) in the amidic aromatic ring. The blood-brain barrier penetration predictions resulted to be promising for this type of compounds. To better understand the structure-activity relationships (SAR) of the new derivatives, a docking study procedure has been applied exploiting different conformational and ionic states of BACE1. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：6657 / 6661

页数：5

共 50 条

[41] The potential for BACE1 inhibitors in the treatment of Alzheimer's disease
Hussain, I
IDRUGS, 2004, 7 (07) : 653 - 658
[42] Synthesis and Activity of BACE1 Inhibitors with New Core Structure
Men Xiu-Feng
He Jun-Lin
Xu Liang
Cheng Jun-Ping
Zhou Jin-Wu
Cheng Xiao-Rui
Zhou Wen-Xia
Zhang Yong-Xiang
Liu Ke-Liang
CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2011, 32 (02): : 316 - 321
[43] Application of Free Energy Perturbation for the Design of BACE1 Inhibitors
Ciordia, Myriam
Perez-Benito, Laura
Delgado, Francisca
Trabanco, Andres A.
Tresadern, Gary
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (09) : 1856 - 1871
[44] BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease
Ghosh, Arun K.
Osswald, Heather L.
CHEMICAL SOCIETY REVIEWS, 2014, 43 (19) : 6765 - 6813
[45] Development of 2-aminoquinolines as potent inhibitors of BACE1
Cheng, Yuan
Ashton, Kate
Bartberger, Michael D.
Brown, James
Chen, Kui
Fremeau, Robert T., Jr.
Harried, Scott
Hickman, Dean
Hitchcock, Stephen A.
Jordan, Brad
Judd, Ted C.
Li, Vivian
Lopez, Patricia
Louie, Steven W.
Lu, Yi
Mercede, Stephanie
Michelsen, Klaus
Nixey, Thomas
Paras, Nick A.
Poon, Steve
Powers, Timothy S.
Rattan, Claire
Sickmier, E. Allen
St Jean, David J., Jr.
Tegley, Christopher M.
Zhong, Wenge
Wen, Paul H.
Wahl, Robert C.
Wood, Stephen
Xue, May
Yang, Bryant
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
[46] Design and discovery of macrocyclic diaminopropanes as potent inhibitors of BACE1
Marcin, Lawrence R.
Thompson, Lorin A.
Higgins, Mendi A.
Shi, JianLiang
Boy, Kenneth M.
Olson, Richard E.
Good, Andrew C.
Burton, Catherine R.
Barten, Donna M.
Muckelbauer, Jodi K.
Calambur, Deepa
Camac, Daniel M.
Chang, ChiehYing
Toyn, Jeremy H.
Lentz, Kimberley A.
Grace, James E.
Herbst, Grace John J.
Marino, Anthony M.
Meredith, Jere E.
Albright, Charlie F.
Macor, John E.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[47] α-Naphthylaminopropan-2-ol Derivatives as BACE1 Inhibitors
Asso, Valentina
Ghilardi, Elisa
Bertini, Simone
Digiacomo, Maria
Granchi, Carlotta
Minutolo, Filippo
Rapposelli, Simona
Bortolato, Andrea
Moro, Stefano
Macchia, Marco
CHEMMEDCHEM, 2008, 3 (10) : 1530 - 1534
[48] Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Coimbra, Judite R. M.
Marques, Daniela F. F.
Baptista, Salete J.
Pereira, Claudia M. F.
Moreira, Paula I.
Dinis, Teresa C. P.
Santos, Armanda E.
Salvador, Jorge A. R.
FRONTIERS IN CHEMISTRY, 2018, 6
[49] Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors
Xu, Ying-zi
Yuan, Shendong
Bowers, Simeon
Hom, Roy K.
Chan, Wayman
Sham, Hing L.
Zhu, Yong L.
Beroza, Paul
Pan, Hu
Brecht, Eric
Yao, Nanhua
Lougheed, Julie
Yan, Jiangli
Tam, Danny
Ren, Zhao
Ruslim, Lany
Bova, Michael P.
Artis, Dean R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 3075 - 3080
[50] Discovery of cyclic acylguanidines as potent and selective BACE1 inhibitors
Zhu, Zhaoning
Sun, Zhong-Yue
Ye, Yuanzan
Durkin, James
Mazzola, Robert D.
Caldwell, John
Smith, Elizabeth
Nechuta, Terry
Cumming, Jared
Wang, Lingyan
Kong, Jianshe
Meng, Tao
Wyss, Daniel
Wang, Allen Yu-Sen
Senior, Mary
Voigt, Johannes
Strickland, Corey
Kennedy, Matthew
Chen, Xia
Kuvelkar, Reshma
Favorau, Lenard
Parker, Eric
McKittrick, Brian
Stamford, Andrew
Madison, Vincent
Czarniecki, Michael
Greenlee, William
Hunter, John
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238

← 1 2 3 4 5 →